Sarah is a Clinical Immunologist/Immunopathologist and Scientia Senior Lecturer. She graduated from a BSc(HonsI)/BA (English) prior to a combined MBBS(Hons)/PhD program. Sarah completed specialist medical training in Clinical Immunology and Immunopathology at St Vincent's, Royal Prince Alfred, Concord, Liverpool and Campbelltown Hospitals and gained dual fellowships of the Royal Australasian College of Physicians and Royal College of Pathologists Australasia in 2017. From 2018-2019 Sarah undertook postdoctoral studies at the University of Oxford investigating autoimmune toxicities of immune checkpoint inhibitors in Professor Paul Klenerman's laboratory.
Sarah's broad research area is human translational Immunology with particular interests in T cell biology and how this relates to the control of cancers and infections including respiratory sepsis.
Broad Research Areas:
Immunology, Infectious Diseases, Cancer Immunology, Immune Checkpoint Inhibitors, Mucosal Immunology, Sepsis
BA, BSc(Hons I), MBBS(Hons), PhD, FRACP, FRCPA
2021-22 NIH R21 Co-infection and Cancer
2020 Kirby Institute Emerging Investigator Award
2020 Australian Intensive Care Foundation Grant
2019 University of Oxford Human Immunology Discovery Initiative Grant
2019 University of Oxford Medical Sciences Division Pump-Prime Grant
2019 Nanostring Autoimmunity Grant
2018-19 Oxford-Celgene Postdoctoral Fellowship
2013 SydPath Research Grant
2006 NHMRC Dora Lush (Biomedical) PhD Scholarship
2004 Centre for Immunology PhD Scholarship